Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07492329Not ApplicableActive Not Recruiting

Antibiotics vs Surgery in Acute Appendicitis

Role: lead

NCT06986564Completed

Evaluation of Decision Compatibility Between a Multidisciplinary Cancer Board and ChatGPT-4O

Role: lead

NCT05872932Phase 2Completed

Outcome of Combined Botulinum Toxin A Injection and Gastric Balloon Implantation in Obesity Treatment

Role: lead

NCT05648084Completed

Artificial Intelligence and Cancer Staging in Upper Gastrointestinal Malignancies

Role: lead

All 4 trials loaded